van Bunningen B, Bouma J, Kooijman C, Wárlám-Rodenhuis C C, Heintz A P, van Lindert A
Department of Radiotherapy and Gynaecology, The Netherlands Cancer Institute (Antoni van Leeuwenhoekhuis), Amsterdam.
Radiother Oncol. 1988 Apr;11(4):305-10. doi: 10.1016/0167-8140(88)90201-0.
In the period from 1981 to 1986, 85 patients with ovarian carcinoma stage I and II were treated in a prospective study. All patients underwent primary surgery: bilateral salpingo-oophorectomy, hysterectomy and omentectomy followed by a staging procedure. In 46 patients, the staging was completed by a retroperitoneal lymph-node dissection, whereas in 39 patients, this procedure was omitted. Total abdominal irradiation (25 Gy/1.50 Gy per fraction) was followed by a pelvic boost dose (25 Gy/1.75 Gy per fraction). Patients with stage I and IIa well differentiated tumours received no adjuvant radiotherapy and are not reported here. The 5-year actuarial recurrence-free survival rate for the irradiated group was 75%. Stage according to FIGO appeared to be of significant prognostic influence. There was no difference in survival between completely and incompletely staged patients. Serious (small) bowel complications occurred however in 6 out of 45 patients who had undergone complete staging.
在1981年至1986年期间,对85例Ⅰ期和Ⅱ期卵巢癌患者进行了一项前瞻性研究。所有患者均接受了初次手术:双侧输卵管卵巢切除术、子宫切除术和大网膜切除术,随后进行分期手术。46例患者通过腹膜后淋巴结清扫完成分期,而39例患者省略了该手术。全腹照射(25 Gy/每次分割1.50 Gy)后给予盆腔追加剂量(25 Gy/每次分割1.75 Gy)。Ⅰ期和Ⅱa期高分化肿瘤患者未接受辅助放疗,此处未报告。放疗组的5年精算无复发生存率为75%。根据国际妇产科联盟(FIGO)分期似乎对预后有显著影响。完全分期和不完全分期患者的生存率没有差异。然而,在45例接受完全分期的患者中,有6例出现了严重(轻微)的小肠并发症。